...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question

In my opinion, ZCC (Zenith Epigenetics as we know it) needed to set this up on the OTC in the first place for the shares to be traded on the OTC. And we know that has not happened as we're told. So what's being traded with a ticker symbol ZHCLF on the OTC cannot be the Zenith CC we know of.

Investopedia:

"Before a company can post a quote for its OTC security, it must first recruit a market maker to sponsor the issue. Only market makers are allowed to apply to have a quote listed on the board, and only one market maker is needed per security issued. Since the securities are technically "not listed" on the OTCBB, the issuing company does not have to pay any fees to have its shares quoted. Market makers, however, must pay a fee of six dollars per security per month for all of the securities that they quote on the board."

 

Koo

Share
New Message
Please login to post a reply